Intercept Pharmaceuticals | 負債

Debt 変化する 日付
Acadia Pharmaceuticals USD 0 0 2022-06
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amarin USD 0 0 2022-06
Amgen USD 64.61B 4.15B 2023-12
Arrowhead Research USD 263.06M 263.06M 2023-06
AstraZeneca USD 28.58B 1.26B 2023-09
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Incyte USD 32.6M 678K 2023-12
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Moderna USD 575M 150M 2023-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Intercept Pharmaceuticals 負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.